QUOTIENT LIMITED 
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Take advantage of the offer
* See conditions on site
More news
More press releases
| Managers | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 56 | 01/21/01 | |
Ali Kiboro
DFI | Director of Finance/CFO | - | 01/21/01 |
Michael Hausmann
CTO | Chief Tech/Sci/R&D Officer | - | 01/21/01 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 56 | 01/21/01 | |
Bradley Meyer
BRD | Director/Board Member | - | 16/23/16 |
James Gaudin
BRD | Director/Board Member | - | 09/23/09 |
Quotient Limited is a Switzerland-based diagnostics company. The Company focuses on blood grouping and donor disease screening, which is referred to as transfusion diagnostics. It is engaged in developing, manufacturing and commercializing conventional reagent products used for blood grouping within the global transfusion diagnostics market. It is engaged in developing MosaiQ, which is its technology platform. The Company develops, manufactures and commercializes the products, including antisera products, reagent red blood cells, whole blood controls and ancillary products. Additionally The Company develops, manufactures and sells conventional reagent products to original equipment manufacturers (OEMs).
Sector
Pharmaceuticals
| 1st Jan change | Capi. | |
|---|---|---|
| -18.00% | 57.63M |
